Atossa Therapeutics, Inc. (ATOS)
NASDAQ·Healthcare·Biotechnology
$2.35
-2.69%
Mkt Cap $39.35M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+325.5%
Consensus $10.00 vs current $2.35
NASDAQ·Healthcare·Biotechnology
$2.35
-2.69%
Mkt Cap $39.35M
No recent rating data.
Price Target (2 analysts)
$10.00
Range $10.00 – $10.00
+325.5%
Consensus $10.00 vs current $2.35